Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-12-001341)

Filing Details

Accession Number:: 0001104659-12-001341
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-01-10 14:27:35
Reporting Period:: 2012-01-06

Filing Date:: 2012-01-10
Accepted Time:: 2012-01-10 14:27:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1316175	Anthera Pharmaceuticals Inc	ANTH	Pharmaceutical Preparations (2834)	201852016

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1281719	Debra Odink	C/O Anthera Pharmaceuticals, Inc. 25801 Industrial Blvd Suite B Hayward CA 94545	Chief Technology Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-01-06	1,200	$6.50	24,441	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	95,928	Indirect	By the Debra A. Odink Living Trust

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011.